» Articles » PMID: 20368670

Role of Glycans and Glycosyltransferases in the Regulation of Notch Signaling

Overview
Journal Glycobiology
Date 2010 Apr 7
PMID 20368670
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

The evolutionarily conserved Notch signaling pathway plays broad and important roles during embryonic development and in adult tissue homeostasis. Unlike most other pathways used during animal development, Notch signaling does not rely on second messengers and intracellular signaling cascades. Instead, pathway activation results in the cleavage of the Notch intracellular domain and its translocation into the nucleus, where it functions as a transcriptional co-activator of the Notch target genes. To ensure tight spatial and temporal regulation of a pathway with such an unusually direct signaling transduction, animal cells have devised a variety of specialized modulatory mechanisms. One such mechanism takes advantage of decorating the Notch extracellular domain with rare types of O-linked glycans. In this review, we will discuss the genetic and biochemical data supporting the notion that carbohydrate modification is essential for Notch signaling and attempt to provide a brief historical overview of how we have learned what we know about the glycobiology of Notch. We will also summarize what is known about the contribution of specific nucleotide-sugar transporters to Notch biology and the roles-enzymatic and non-enzymatic-played by specific glycosyltransferases in the regulation of this pathway. Mutations in the Notch pathway components cause a variety of human diseases, and manipulation of Notch signaling is emerging as a powerful tool in regenerative medicine. Therefore, studying how sugar modification modulates Notch signaling provides a framework for better understanding the role of glycosylation in animal development and might offer new tools to manipulate Notch signaling for therapeutic purposes.

Citing Articles

Proteome-wide mendelian randomization study implicates therapeutic targets in common cancers.

Ren F, Jin Q, Liu T, Ren X, Zhan Y J Transl Med. 2023; 21(1):646.

PMID: 37735436 PMC: 10512580. DOI: 10.1186/s12967-023-04525-5.


In-depth quantitative proteomics analysis revealed C1GALT1 depletion in ECC-1 cells mimics an aggressive endometrial cancer phenotype observed in cancer patients with low C1GALT1 expression.

Montero-Calle A, Lopez-Janeiro A, Mendes M, Perez-Hernandez D, Echevarria I, Ruz-Caracuel I Cell Oncol (Dordr). 2023; 46(3):697-715.

PMID: 36745330 PMC: 10205863. DOI: 10.1007/s13402-023-00778-w.


Notch signaling pathway: architecture, disease, and therapeutics.

Zhou B, Lin W, Long Y, Yang Y, Zhang H, Wu K Signal Transduct Target Ther. 2022; 7(1):95.

PMID: 35332121 PMC: 8948217. DOI: 10.1038/s41392-022-00934-y.


The Notch signaling pathway involvement in innate lymphoid cell biology.

Golub R Biomed J. 2021; 44(2):133-143.

PMID: 33863682 PMC: 8178581. DOI: 10.1016/j.bj.2020.12.004.


Notch signaling: Its essential roles in bone and craniofacial development.

Pakvasa M, Haravu P, Boachie-Mensah M, Jones A, Coalson E, Liao J Genes Dis. 2021; 8(1):8-24.

PMID: 33569510 PMC: 7859553. DOI: 10.1016/j.gendis.2020.04.006.


References
1.
Chen J, Moloney D, Stanley P . Fringe modulation of Jagged1-induced Notch signaling requires the action of beta 4galactosyltransferase-1. Proc Natl Acad Sci U S A. 2001; 98(24):13716-21. PMC: 61107. DOI: 10.1073/pnas.241398098. View

2.
Tien A, Rajan A, Bellen H . A Notch updated. J Cell Biol. 2009; 184(5):621-9. PMC: 2686403. DOI: 10.1083/jcb.200811141. View

3.
Hambleton S, Valeyev N, Muranyi A, Knott V, Werner J, McMichael A . Structural and functional properties of the human notch-1 ligand binding region. Structure. 2004; 12(12):2173-83. DOI: 10.1016/j.str.2004.09.012. View

4.
Sasaki N, Sasamura T, Ishikawa H, Kanai M, Ueda R, Saigo K . Polarized exocytosis and transcytosis of Notch during its apical localization in Drosophila epithelial cells. Genes Cells. 2007; 12(1):89-103. DOI: 10.1111/j.1365-2443.2007.01037.x. View

5.
Oda T, Elkahloun A, Pike B, Okajima K, Krantz I, Genin A . Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nat Genet. 1997; 16(3):235-42. DOI: 10.1038/ng0797-235. View